Analysis of extracted cardiac device leads for bacteria type: clinical impact

References

• Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–a World Society of Arrhythmia’s project. Pacing Clin. Electrophysiol. 34(8), 1013–1027 (2011).
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Ochoa JA, Lau E et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993–2006. Pacing Clin. Electrophysiol. 33(6), 705–711 (2010).
   PubMed Web of Science ®Google Scholar
• Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin. Electrophysiol. 33(4), 414–419 (2010).
   PubMed Web of Science ®Google Scholar
• Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur. Heart J. 32(8), 991–998 (2011).
   PubMed Web of Science ®Google Scholar
• Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads. Circulation 95, 2098–2107 (1997).
   PubMed Web of Science ®Google Scholar
• Conklin EF, Giannelli S Jr, Ayres SM, Mueller HS, Grace WJ. Prevention of pacemaker infections. NY State J. Med. 73(22), 2675–2677 (1973).
   PubMedGoogle Scholar
• Bluhm. Pacemaker infections. A 2-year follow-up of antibiotic prophylaxis. Scand. J. Thorac. Cardiovasc. Surg. 19(3), 231–235 (1985).
   PubMed Web of Science ®Google Scholar
• Arber N, Pras E, Copperman Y et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 73(6), 299–305 (1994).
   PubMed Web of Science ®Google Scholar
• Catanchin A, Murdock CJ, Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ. doi:10.1016/j.hlc.2007.1002.1097 (2007).
   PubMedGoogle Scholar
• Tsai FS, Aronow WS, Devabhaktuni S et al. Prevalence of complications during implantation and during 38-month follow-up of 1060 consecutive patients with implantable cardioverter-defibrillators. Am. J. Ther. 17(1), e8–10 (2010).
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J. Am. Coll. Cardiol. 58(10), 1001–1006 (2011).
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med. 167(7), 669–675 (2007).
   PubMed Web of Science ®Google Scholar
• Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116(12), 1349–1355 (2007).
   PubMed Web of Science ®Google Scholar
• Jan Willem Borleffs C, Thijssen J, de Bie MK et al. Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin. Electrophysiol. 33(8), 1013–1019 (2010).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Daubert J, Zareba W. MADIT-II: clinical implications. Card. Electrophysiol. Rev. 6(4), 463–465 (2002).
   PubMedGoogle Scholar
• Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am. J. Cardiol. 88(7), 750–753 (2001).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Risk factor analysis of permanent pacemaker infection. Clin. Infect. Dis. 45(2), 166–173 (2007).
   PubMed Web of Science ®Google Scholar
• Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361(14), 1329–1338 (2009).
   PubMed Web of Science ®Google Scholar
• van Rees JB, de Bie MK, Thijssen J, Borleffs CJ, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J. Am. Coll. Cardiol. 58(10), 995–1000 (2011).
   PubMed Web of Science ®Google Scholar
• Poole JE, Gleva MJ, Mela T et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 122(16), 1553–1561 (2010).
   PubMed Web of Science ®Google Scholar
• Duval X, Selton-Suty C, Alla F et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin. Infect. Dis. 39(1), 68–74 (2004).
   PubMed Web of Science ®Google Scholar
• del Rio A, Anguera I, Miro JM et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 124(4), 1451–1459 (2003).
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Prutkin JM, Sohail MR et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J. Am. Coll. Cardiol. 59(7), 681–687 (2012).
   PubMed Web of Science ®Google Scholar
• Chua JD, Wilkoff BL, Lee I, Longworth D, Gordon SM. Diagnosis and management of infection involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133, 604–608 (2000).
   PubMed Web of Science ®Google Scholar
• Klug D, Wallet F, Lacroix D et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 90(8), 882–886 (2004).
   PubMed Web of Science ®Google Scholar
• Dy Chua J, Wilkoff BL, Lee I, Longworth D, Gordon SM. Diagnosis and management of infection involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133, 604–608 (2000).
   PubMed Web of Science ®Google Scholar
• Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95(8), 2098–2107 (1997).
   PubMed Web of Science ®Google Scholar
• Golzio PG, Gabbarini F, Anselmino M, Vinci M, Gaita F, Bongiorni MG. Gram-positive occult bacteremia in patients with pacemaker and mechanical valve prosthesis: a difficult therapeutic challenge. Europace 12(7), 999–1002 (2010).
   PubMed Web of Science ®Google Scholar
• Victor F, De Place C, Camus C et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 81(1), 82–87 (1999).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin. Proc. 83(1), 46–53 (2008).
   PubMed Web of Science ®Google Scholar
• Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand. J. Infect. Dis. 36(9), 674–679 (2004).
   PubMed Web of Science ®Google Scholar
• Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol. 82(4), 480–484 (1998).
   PubMed Web of Science ®Google Scholar
• Bongiorni MG, Di Cori A, Soldati E et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 25(6), 632–638 (2008).
   PubMed Web of Science ®Google Scholar
• Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J. Am. Soc. Echocardiogr. 15(9), 1027–1028 (2002).
   PubMed Web of Science ®Google Scholar
• Narducci ML, Pelargonio G, Russo E et al. Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J. Am. Coll. Cardiol. 61(13), 1398–1405 (2013).
   PubMed Web of Science ®Google Scholar
• Downey BC, Juselius WE, Pandian NG, Estes NA 3rd, Link MS. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin. Electrophysiol. 34(6), 679–683 (2011).
   PubMed Web of Science ®Google Scholar
• Lo R, D’Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms. J. Invasive Cardiol. 18(12), 599–601 (2006).
   PubMedGoogle Scholar
• Supple GE, Ren JF, Zado ES, Marchlinski FE. Mobile thrombus on device leads in patients undergoing ablation: identification, incidence, location, and association with increased pulmonary artery systolic pressure. Circulation 124(7), 772–778 (2011).
   PubMed Web of Science ®Google Scholar
• Bennett CJ, Maleszewski JJ, Araoz PA. CT and MR imaging of the aortic valve: radiologic-pathologic correlation. Radiographics 32(5), 1399–1420 (2012).
   PubMed Web of Science ®Google Scholar
• Cook RJ, Ashton RW, Aughenbaugh GL, Ryu JH. Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest 128(1), 162–166 (2005).
   PubMed Web of Science ®Google Scholar
• Sarrazin JF, Philippon F, Tessier M et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J. Am. Coll. Cardiol. 59(18), 1616–1625 (2012).
   PubMed Web of Science ®Google Scholar
• Brinker J. Imaging for infected cardiac implantable electronic devices: a new trick for your pet. J. Am. Coll. Cardiol. 59(18), 1626–1628 (2012).
   PubMed Web of Science ®Google Scholar
• Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J. Nucl. Med. 51(12), 1937–1949 (2010).
   PubMed Web of Science ®Google Scholar
• Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Q. J. Nucl. Med. Mol. Imaging 52(1), 17–29 (2008).
   PubMed Web of Science ®Google Scholar
• Bleeker-Rovers CP, Vos FJ, Wanten GJ et al. 18F-FDG PET in detecting metastatic infectious disease. J. Nucl. Med. 46(12), 2014–2019 (2005).
   PubMed Web of Science ®Google Scholar
• Corstens FH, van der Meer JW. Nuclear medicine’s role in infection and inflammation. Lancet 354(9180), 765–770 (1999).
   PubMed Web of Science ®Google Scholar
• Howarth DM, Curteis PG, Gibson S. Infected cardiac pacemaker wires demonstrated by Tc-99 m labeled white blood cell scintigraphy. Clin. Nucl. Med. 23(2), 74–76 (1998).
   PubMed Web of Science ®Google Scholar
• Turpin S, Lambert R, Poirier N. An unusual looking pacemaker infection imaged with 18F-FDG PET/CT. Eur. J. Nucl. Med. Mol. Imaging 37(7), 1438 (2010).
   PubMed Web of Science ®Google Scholar
• Abikhzer G, Turpin S, Bigras JL. Infected pacemaker causing septic lung emboli detected on FDG PET/CT. J. Nucl. Cardiol. 17(3), 514–515 (2010).
   PubMed Web of Science ®Google Scholar
• Khamaisi M, Medina A, Mazouz B, Bocher M. Imaging coronary sinus infection in pacemaker electrode with [18F]-fluorodeoxyglucose positron emission tomography. J. Cardiovasc. Electrophysiol. 19(12), 1327–1328 (2008).
   PubMed Web of Science ®Google Scholar
• Vos FJ, Bleeker-Rovers CP, van Dijk AP, Oyen WJ. Detection of pacemaker and lead infection with FDG-PET. Eur. J. Nucl. Med. Mol. Imaging 33(10), 1245 (2006).
   PubMed Web of Science ®Google Scholar
• Erba PA, Conti U, Lazzeri E et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J. Nucl. Med. 53(8), 1235–1243 (2012).
   PubMed Web of Science ®Google Scholar
• Ploux S, Riviere A, Amraoui S et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm 8(9), 1478–1481 (2011).
   PubMed Web of Science ®Google Scholar
• Klug D, Messaudene SA, Marquie C et al. Prospective evaluation of new criteria for the diagnosis of pacemaker lead infection: limitation of the clinical Duke criteria for the diagnosis of endocarditis. Heart Rhythm 2, S249 (2005).
   Google Scholar
• Dy Chua J, Abdul-Karim A, Mawhorter S et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pac Clin. Electrophysiol. 28, 1276–1281 (2006).
   Web of Science ®Google Scholar
• Klug D, Wallet F, Kacet S, Courcol R. Detailed bacteriological tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am. Heart J. 149(2), 322–328 (2005).
   PubMed Web of Science ®Google Scholar
• Golzio PG, Vinci M, Anselmino M et al. Accuracy of swabs, tissue specimens, and lead samples in diagnosis of cardiac rhythm management device infections. Pacing Clin. Electrophysiol. 32(Suppl. 1), S76–80 (2009).
   Web of Science ®Google Scholar
• Kolker AR, Redstone JS, Tutela JP. Salvage of exposed implantable cardiac electrical devices and lead systems with pocket change and local flap coverage. Ann. Plast. Surg. 59(1), 26–29; discussion 30 (2007).
   PubMed Web of Science ®Google Scholar
• Turkisher V, Priel I, Dan M. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device. PACE 20, 268–2270 (1997).
   Google Scholar
• Yamada M, Takeuchi S, Shiojiri Y et al. Surgical lead-preserving procedures for pacemaker pocket infections. Ann. Thorac. Surg. 74, 1494–1499 (2002).
   PubMed Web of Science ®Google Scholar
• Lewis A, Hayes D, Holmes D. Update on infections involving permanent pacemakers. Characterization and management. J. Thorac. Cardiovasc. Surg. 89, 758–763 (1985).
   PubMed Web of Science ®Google Scholar
• Molina JE. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. Ann. Thorac. Surg. 63(2), 504–509 (1997).
   PubMed Web of Science ®Google Scholar
• Vogt PR, Sagdic K, Lachat M. Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J. Card. Surg. 11, 180–186 (1996).
   PubMed Web of Science ®Google Scholar
• Parry G, Goudevenos J, Jameson S. Complications associated with retained pacemaker leads. Pacing Clin. Eletrophysiol. 14, 1251–1257 (1991).
   PubMed Web of Science ®Google Scholar
• Siu CW, Cheng LC, Woo PC, Lau CP, Tse HF. A patient with relapsing pacemaker infection due to “Gram-positive bacilli”. Int. J. Cardiol. 114(2), E40–41 (2007).
   Google Scholar
• Tsai V, Chen H, Hsia H, Zei P, Wang P, Al-Ahmad A. Cardiac device infections complicated by erosion. J. Interv. Card. Electrophysiol. 19(2), 133–137 (2007).
   PubMed Web of Science ®Google Scholar
• Kaur MR, Gach JE, Marshall H, Lewis HM. Recurrent postoperative pyoderma gangrenosum complicating pacemaker insertion. J. Eur. Acad. Dermatol. Venereol. 20(4), 466–467 (2006).
   PubMed Web of Science ®Google Scholar
• Nandyala R, Parsonnet V. One stage side-to-side replacement of infected pulse generators and leads. Pacing Clin. Electrophysiol. 29(4), 393–396 (2006).
   PubMed Web of Science ®Google Scholar
• Tascini C, Bongiorni MG, Gemignani G et al. Management of cardiac device infections: A retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal. J. Chemother. 18(2), 157–163 (2006).
   PubMed Web of Science ®Google Scholar
• Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am. J. Med. Sci. 322(4), 209–212 (2001).
   PubMed Web of Science ®Google Scholar
• Dy Chua J, Abdul-Karim A, Mawhorter S et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin. Electrophysiol. 28(12), 1276–1281 (2005).
   PubMed Web of Science ®Google Scholar
• Darouiche R. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350(14), 1422–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Golzio PG, Fanelli AL, Vinci M et al. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Europace 15(1), 89–100 (2012).
   PubMed Web of Science ®Google Scholar
• Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol. 82, 480–484 (1998).
   PubMed Web of Science ®Google Scholar
• Bongiorni MG, Tascini C, Tagliaferri E et al. Microbiology of cardiac implantable electronic device infections. Europace 14(9), 1334–1339 (2012).
   PubMed Web of Science ®Google Scholar
• Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J. Am. Coll. Cardiol. 49(18), 1851–1859 (2007).
   PubMed Web of Science ®Google Scholar
• Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular cardiovascular device-related infections. Circulation 108(16), 2015–2031 (2003).
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Rhim ES, Mark G, Desimone J, Ho RT. Lead-associated endocarditis: the important role of methicillin-resistant Staphylococcus aureus. Pacing Clin. Electrophysiol. 31(5), 548–553 (2008).
   PubMed Web of Science ®Google Scholar